Group 1 - The core viewpoint of the news is that Wanze Co., Ltd. has seen an increase in shareholder accounts despite a decline in stock price during the same period [1][2] - As of June 30, 2025, the number of shareholders for Wanze Co., Ltd. reached 23,143, an increase of 3,542 accounts or 18.07% compared to March 31, 2025 [1][2] - The average shareholding value per account for Wanze Co., Ltd. is 325,000 yuan, which is below the industry average of 422,200 yuan for biopharmaceutical companies [1][2] Group 2 - From March 31, 2025, to June 30, 2025, Wanze Co., Ltd. experienced a stock price decline of 4.85% while simultaneously increasing its shareholder accounts [1][2] - During the same period, the net outflow of main funds was 273 million yuan, while retail investors contributed a net inflow of 198 million yuan [2]
万泽股份6月30日股东户数2.31万户,较上期增加18.07%